NCT06408129Completed
COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)
Source: ClinicalTrials.gov · Last updated 9 May 2024
Brief summary (registry, in English)
The study is an evaluation of the diagnostic performance of different tests and their association in order to confirm or exclude active tuberculosis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 580 (actual)
- First submitted
- 9 Apr 2024
- Start date
- 31 Jan 2017
- Primary completion date
- 31 Dec 2022
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Tuberculosis
- NCT number
- NCT06408129
What you commit to
- Study type: Observational
- Participants enrolled: 580
- From 31 Jan 2017 to the primary completion date, 31 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Major patients who received the following examinations at the Montpellier University Hospital for tuberculosis screening (clinical suspicion and/or contact with a person with active tuberculosis):
- Chest X-ray AND
- Chest CT scan AND
- Mycobacteriology examination of respiratory or tissue sample (direct/culture/GenXpert) AND
- IGRA test (Quantiferon)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uh Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.